Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steve Elms


  • Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2019-07-15
  • Large Shareholder at Zosano Pharma Corp (ZSAN), 2019-04-12
  • Director at Adma Biologics Inc. (ADMA), 2019-03-15
  • Large Shareholder, Director at Loxo Oncology Inc. (LOXO), 2019-02-15
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Director at Pernix Therapeutics Holdings Inc. (PTX), 2016-05-31
  • Large Shareholder at Viewray Inc. (VRAY), 2016-03-30
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder, Director at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-04-27
  • Director at Cidara Therapeutics Inc. (CDTX), 2015-04-22
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Director at Ambit Biosciences Corp (AMBI), 2014-09-05
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
  • Large Shareholder at Cempra Inc. (CEMP), 2012-02-09
  • Director at Map Pharmaceuticals Inc. (MAPP), 2010-05-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $13.00 413,077 Large Shareholder, Director 3,452,493 2014-08-06 Filing
AMBI $8.00 423,635 Director 1,546,444 2013-05-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MAPP $16.15 2,090 Director 0 2010-03-10 Filing